7 results
Venous Thromboembolism Treatment Algorithm
Branch points: 
Active bleeding?  Active malignancy? Provoked?

- Dr. Joseph Shatzel
@Clotmaster

#Management #VTE #DVT
Venous Thromboembolism ... Treatment Algorithm ... points: Active bleeding ... #Algorithm #Venous ... #Anticoagulation
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
for the treatment ... DVT = deep vein ... thromboembolism ... #Cancer #Algorithm ... #Anticoagulation
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... and incidental DVT ... DOAC, direct oral ... #Cancer #Algorithm ... #Anticoagulation
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Longterm Venous ... Thromboembolism ... Treatment Algorithm ... #Treatment #Algorithm ... management #hematology #anticoagulation
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
of Therapy for Venous ... Thromboembolic ... Thrombophilia • Cancer ... Bloodman #VTE #anticoagulation ... hematology #length #treatment
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

https://www.nejm.org/doi/full/10.1056/NEJMoa1711948

Authors’ Conclusions: “Oral edoxaban was noninferior to subcutaneous dalteparin
Edoxaban for the Treatment ... of Cancer-Associated ... Venous Thromboembolism ... KirstyChallen #Edoxaban #Cancer ... VisualAbstract #DVT
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Avoid Warfarin and DOAC ... Considerations • Thromboembolic ... suggest prophylactic anticoagulation ... teratogenic GDMT meds ... management #cardiology #treatment